Oncology Today with Dr Neil Love artwork

What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Oncology Today with Dr Neil Love

English - October 06, 2023 15:30 - 47 minutes - 27.3 MB
Medicine Health & Fitness Science dr neil love research to practice oncology today oncology cme Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer
Next Episode: Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series

Professor Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here (https://www.researchtopractice.com/MonoclonalAntibodiesMM23)

Professor Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here